| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q/C TECHNOLOGIES, INC. | Director, Chief Medical Off., Director | Common stock | 12,500 | $42,250 | $3.38 | 14 Nov 2025 | Direct |
| TNF Pharmaceuticals, Inc. | Director, Chief Medical Off., Director | Employee Stock Option (Right to Buy) | 125,000 | 17 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNFA | Q/C TECHNOLOGIES, INC. | 14 Nov 2025 | 1 | $0 | 4 | Director, Chief Medical Off., Director | 17 Nov 2025, 17:30 |
| TNFA | Q/C TECHNOLOGIES, INC. | 03 Oct 2025 | 1 | $0 | 4 | Director, Chief Medical Off., Director | 06 Oct 2025, 17:30 |
| TNFA | TNF Pharmaceuticals, Inc. | 17 Apr 2025 | 1 | $0 | 4 | President, CMO, Director | 18 Apr 2025, 16:30 |
| TNFA | MyMD Pharmaceuticals, Inc. | 08 Apr 2024 | 0 | $0 | 3 | Director | 16 May 2024, 17:30 |